Skip to main content
. 2022 Feb 6;14(3):829. doi: 10.3390/cancers14030829

Table 2.

Clinicopathological characteristics of patients with ovarian cancer according to P1 tumor engraftment status.

Successful Engraftment
Variables Case Successful Engraftment Failed Engraftment p Value Tumor Growth Rate a p Value d
All, n 130 61 69
Age (year) a 52.12 ± 12.22 52.08 ± 12.51 52.16 ± 12.05 0.9706 b
Pre CA-125 level (U/mL) a 942.7 ± 2315 1442 ± 3124 475.4 ± 942.7 0.0216 b
Borderline tumors, n 10 2 8
Histology, n (%) 1.0000 c
Serous 2 (20.00) 0 (0.0) 2 (25.00) N/A N/A
Mucinous 8 (80.00) 2 (100) 6 (75.00) 167.55 ± 102.2
Malignant tumors, n 120 59 61
Epithelial ovarian cancer, n 112 54 58
Histology, n (%) 0.0389 c
Serous 68 (60.71) 39 (72.22) 29 (50.00) 300.9 ± 248.3 reference
Clear 17 (15.18) 6 (11.11) 11 (18.97) 395.4 ± 383.1 0.6088
Endometrioid 7 (6.25) 2 (3.70) 5 (8.62) 90.28 ± 2.653 <0.0001
Mucinous 12 (10.71) 2 (3.70) 10 (17.24) 373.5 ± 322.0 0.807
MMMT 7 (6.25) 5 (9.26) 2 (3.45) 632.7 ± 696.4 0.059
Brenner 1 (0.89) 0 (0.0) 1 (1.72) N/A N/A
Stage, n (%) 0.0004 c
I 27 (24.11) 5 (9.26) 22 (37.93) 112.6 ± 53.89 reference
II/III/IV/Recurrent 85 (75.89) 49 (90.74) 36 (62.07) 359.3 ± 335.1 0.0002
Grade, n (%) 0.0073 c
1 8 (7.14) 0 (0.0) 8 (13.79) N/A
2 10 (8.93) 7 (12.96) 3 (5.17) 316.6 ± 166.8 reference
3 70 (62.50) 37 (68.52) 33 (56.90) 332.5 ± 287.1 0.2044
Unknown 24 (21.43) 10 (18.52) 14 (24.14) 443.7 ± 521.4 N/A
Non-Epithelial ovarian cancer, n 8 5 3
Histology, n (%) 0.2369 c
Sex cord-stromal 1 (12.50) 0 (0.0) 1 (33.33) N/A N/A
Germ cell 5 (62.50) 3 (60.00) 2 (66.67) 84.12 ± 106.3
Metastatic 2 (25.00) 2 (40.00) 0 (0.0) N/A
Stage, n (%) 0.1964 c
I 5 (62.50) 2 (40.00) 3 (10.00) 159.25 N/A
II/III/IV/Recurrent 3 (37.50) 3 (60.00) 0 (0.0) 8.98

a Values are mean ± standard derivation. b Unpaired t-test for success and failure. c Chi-square test or Fisher’s exact test values for success and failure. d Unpaired t-test with Welch’s correction. Unknown data was excluded in calculation of p value. N/A, not applicable.